BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 11228470)

  • 1. The pharmacokinetics and efficacy of different estrogens are not equivalent.
    Ansbacher R
    Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?].
    Lippert TH; Seeger H; Mueck AO
    Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
    Archer DF
    Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy: estrogen after menopause.
    Gibaldi M
    Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of oral versus non-oral hormonal treatments in menopause].
    Sitruk-Ware R
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):688-93. PubMed ID: 8991902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M; Karakoç B; Gürler A
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG; Herrington DM
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of conjugated equine estrogens in healthy, postmenopausal women.
    Mayer P; Tse S; Sendi M; Bourg D; Morrison D
    J Reprod Med; 2008 Feb; 53(2):97-101. PubMed ID: 18357800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.